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Background: A major aspect of providing mental healthcare is access to and use of psychotropic medications.
Bihar is a state in northeast India with limited mental healthcare provision; consequently access to and utilisation of
psychotropic medications are likely to be limited. However, to date there has been no research assessing the
situation. This study therefore aims to analyse the psychotropic medications management cycle (selection,
procurement, distribution and use), and identify the barriers to access and utilisation, and their underlying causes.
Method: A rapid appraisal method was used in which primary and secondary data sources were collected and
analysed. Semi-structured interviews were conducted with twenty-two stakeholders and twenty-one service users
from the government, non-governmental organisation (NGO) and private sectors. The qualitative data collected was
analysed using a comparative thematic approach. The research was supported by the NGOs BasicNeeds and Nav
Bharat Jagriti Kendra.
Results: Availability, distance and cost were the main barriers to access and utilisation. At the medical college
hospital level a lack of supply appears to be due to a discrepancy between orders made by the hospital and
medications supplied by the manufacturers. At the primary health centre and district hospital level the main barrier
is a cycle between lack of demand for treatments for mental illness by doctors and patients.
Conclusion: Further investigation and monitoring is necessary to ensure the availability of psychotropic
medications at the medical college hospital level. In addition, implementation of the District Mental Health
Programme is likely to address the access and utilisation barriers due to its potential to break the current cycle of
lack of demand.
Keywords: Psychotropic medicines, Resource-limited settings, India, Access, Utilisation, Low- and middle-income
countries, LMICS, Low-income settingsBackground
Neuropsychiatric disorders are a major cause of disabil-
ity worldwide, accounting for approximately 13% of the
global burden of disease [1]. In comparison, malaria, tu-
berculosis and HIV/AIDS, which have been the focus of
huge global initiatives, together account for only 8.2%
[1]. In addition, data from the 2010 Global Burden of
Disease Study demonstrated that mental and substance
use disorders caused the greatest number of years lived
with disability (DALYs) worldwide [2]. In low- and
middle-income countries (LMICs) the burden of mental* Correspondence: prianka.padmanathan@gmail.com
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article, unless otherwise stated.illness is rapidly increasing due to changes in demo-
graphics and epidemiology [3].
One major aspect of providing mental healthcare is
the availability of and access to psychotropic medica-
tions. Worldwide it is estimated that the availability of
generic medicines in the public sector is less than 60%,
which results in a significant lack of access in LMICs
[4]. There is a similar pattern with regard to access to
essential psychotropic medications [5].
In India, a systematic review of epidemiological studies
estimated the point prevalence of mental illness requir-
ing intervention by a mental health professional to be
approximately 20% [6]. These interventions can have an
impact on a number of socioeconomic outcomes, by
improving management of mental illness. For example aentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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governmental organisation (NGO) programme for mental
illness in Bihar and Jharkhand specifically, demonstrated
an improvement in indicators such as employment status,
number of days out of employment due to illness, and
number of hours of care provided by a caregiver [7].
However despite mounting evidence also demonstrating
the efficacy and affordability of existing medical, psycho-
logical and social interventions in low- and middle-income
countries (LMICs), [8] including a number of recent studies
in India, [9-11] it is estimated that 70-80% of those with
mental illness in India do not receive adequate care [12].
To try to address these issues, the Indian government
launched a District Mental Health Programme, which pri-
marily aims to stimulate the development of community-
based mental healthcare [13].
Bihar is the third most populous state in India with
approximately 104 million people, of whom 88.7% live in
rural areas [14]. Between 2009-2010 the state had the
highest percentage of population living below the poverty
line in India [15]. However, this percentage has fallen
sharply from 53.5% to 33.74% between 2011-2012 [16].
During this period Bihar also ranked as the fastest growing
state in terms of gross domestic product [17]. However, to
date no district in Bihar has implemented the District
Mental Health Programme. As a result there is limited
mental healthcare provision within the state and access to
and utilisation of psychotropic medications are likely to
be limited. This research therefore aims to analyse the
psychotropic medications management cycle (selection,
procurement, distribution and use), and identify the bar-
riers to access and utilisation of psychotropic medications
and their underlying causes.
This research was supported by the international non-
governmental organisation BasicNeeds who have formed
a partnership with a local development organisation
called Nav Bharat Jagriti Kendra (NBJK) to implement a
community-based model for Mental Health and Devel-
opment. This comprises of five interlinked modules in-
volving capacity building, community mental health,
livelihoods, research and collaboration.Methods
The study was carried out in five of Bihar’s thirty-eight
districts: Bhojpur, Gaya, Muzaffarpur, Nalanda and Patna.
The choice of districts was based on practicalities such as
distance from Patna and the presence of NBJK partners
who were able to facilitate the organisation of interviews
locally.
A rapid appraisal method was employed, which in-
volved the collection of data from interviews and policy
and administrative documents, such as price lists and
consumption data. Policy and administrative documentswere obtained from stakeholders and by searching the
internet.
Stakeholders were identified using a snowball sampling
strategy, beginning with the programme manager for the
BasicNeeds/NBJK programme. The following stakeholders
were interviewed: one NBJK administrator, two govern-
ment officials, one government administrator, eight psy-
chiatrists covering six medical college hospitals (MCH)
and Bihar Institute of Mental Health and Allied Sciences
(BIMHAS), one medical college hospital administrator,
one district hospital (DH) doctor, four primary health
centre (PHC) doctors, and four community-based workers
(CBW) who follow up over 900 service users between
them. Three pharmacists, one hospital administrator, one
government official and one government administrator
declined to participate due to the requirement to sign an
informed consent form. Twenty-one service users were
also interviewed and were identified by CBWs or their
psychiatrist. They were purposefully selected to include in-
dividuals from four districts and the private, NGO and
government health sectors. The majority of these service
users had experienced care from more than one sector, as
they had switched between services. Interviews were semi-
structured and lasted approximately twenty minutes each.
Specific interview guides were developed for different
types of stakeholders based on BasicNeeds’ experience in
other countries. However, these questions were then de-
veloped iteratively. Interview guides are available from the
corresponding author on request. All interviews were
audio-recorded, although one stakeholder provided re-
sponses to interview questions in writing. Interviews in
Hindi were conducted using a local interpreter.
Data collection and analysis were iterative in order to
test emerging themes. A comparative thematic approach
was used for the analysis of all the qualitative data. Data
was transcribed and coded. Codes were grouped into
themes and the themes were then analysed in relation to
the research question.
Ethical approval was obtained from the University of
Leeds Faculty Research Ethics Committee, UK. Consid-
erable attempts were made to obtain ethical approval in
India; however none of the ethics committees in the
state agreed, due to a lack of registration to approve
such a study.Results
Currently there are three methods of accessing evidence-
based mental healthcare in Bihar: government hospitals,
NGO camps, or private psychiatrists. Government mental
health services are only available at medical college hospi-
tals, and the state’s only mental health hospital, BIMHAS
(Figure 1). Furthermore medications are not regularly
available at the former.
Bihar Instute of Health and 
Allied Sciences (BIMHAS)
Medical college hospitals 
(MCH)
District hospitals (DH)
Primary health centres 
(PHC)
Figure 1 Levels of government-provided healthcare appraised
in study.
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employed by NBJK refer service users to NBJK mental
health camps, which are held monthly in three dis-
tricts. Approximately 400 patients attend the two lar-
gest camps. One psychiatrist is present at each camp,
and the fee charged is considerably lower than those
charged privately. Psychotropic medications are pro-
vided for free. Service users are then followed up in
their own locality by a CBW from one of fourteen local
partner NGOs.
In addition to camps, in Bihar BasicNeeds support
participation in livelihood projects such as agricultural
activities, trades such as carpentry and plumbing and
running small businesses. They also help people with
mental illness and their carers to join self-help groups
and a state level user association which is involved in
advocacy.
Barriers to access and utilisation
Availability
All ten service users currently using the NBJK camps
reported that the medications they required were always
available. However one service user consulting a privatepsychiatrist stated he previously visited the camps, but
began to see the same psychiatrist privately due to a
lack of availability of certain medications. Two CBWs
who follow up approximately 400 service users between
them, clarified that occasionally when a medication was
ineffective the service user would begin consulting a
psychiatrist privately, or the camp psychiatrist would
prescribe an alternative that was unavailable at the
camp. Therefore there were a small number of service
users who had to purchase medication from private
pharmacies.
The doctors at PHCs and a DH confirmed that there
were no psychotropic medications available at the pri-
mary care level, except benzodiazepines which could be
used to temporarily sedate patients whilst transferring
them to MCHs:
“Government do not provide any psychiatric medicines
except for diazepam. Diazepam is available sometimes
at this PHC provided by the government as tablet and
injection. Also can only prescribe diazepam for
epilepsy. Other medicines we don’t have here.”
All four service users interviewed attending MCHs
stated that they had to purchase the medications pre-
scribed from private pharmacies due to lack of availabil-
ity in the hospital.
Out of the three service users from BIMHAS, one
stated that the medications he required were always
available for free, another reported that two of the medi-
cations he was prescribed were available for free but he
had to purchase the third from Patna, and the third de-
scribed occasional shortages during which he had been
told to return 4-5 days later or to buy the medications
from private pharmacies. A CBW who follows up ap-
proximately 120 service users from BIMHAS clarified
this, stating that roughly ten per cent of service users
were required to purchase their medications from pri-
vate pharmacies due to lack of availability. He stated that
most managed to afford the medications, however a few
required financial assistance from the NGO. In contrast
psychiatrists working at BIMHAS stated that there were
no shortages and that every patient was provided free
medications.
As expected service users consulting private psychia-
trists purchased psychotropic medications from private
pharmacies. They reported that these medications were
easily available albeit only in cities such as Patna and
Gaya.Distance
Thirteen service users spent over an hour travelling to
access treatment; six spent over 5 hours travelling. One
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ling to the camp during extreme weather:
“Medicines should be available in nearby areas
because to go to the camp they have to catch the train
early in the morning, but in extreme weather
conditions it is difficult to collect all the patients and
get them into the train. We try to get everyone here the
previous night, but still some get left out and lost due
to fog and it is dangerous because they are mentally
ill”
Another CBW also described the difficulty of travelling
a long distance when acutely mentally unwell. Service
users travelling to BIMHAS were worst affected as medi-
cations were only prescribed for fifteen days, compared
to a month at MCHs and camps. Service users therefore
had to travel to the hospital more frequently. As the ma-
jority of the population lives in rural areas, eight service
users expressed a desire for the treatments to be made
available locally.
Affordability
Out of the four service users currently attending a
MCH, three described difficulties paying for medications
and two had borrowed money to afford them:
“I find it expensive – I am a practitioner of
homeopathy and am earning some money but that is
not enough so I take money from my son.”“Every month for about 2 or 3 days I miss the
medicine. Sometimes because I cannot come to this
place, sometimes because I do not have the money… I
could not afford it easily. I had to take some funds
from a money lender.”
Another service user who had previously attended a
MCH before switching to a camp, stated that she would
try to stop taking the medications as soon as she felt
normal, due to the cost. A psychiatrist at one MCH
stated that he referred his poorest patients to the camp,
as they were unable to afford medications. He could not
however, refer everyone due to a lack of capacity at the
camp.
Although medications are usually available free of cost
at BIMHAS and the camps, five out of the twenty-one
service users struggled to pay for travel. One missed
camps due to a lack of money and therefore did not take
the medication regularly. Another had to borrow money,
and a third had asked someone else who was attending
the camp to pick up the medications on their behalf. A
service user who had previously been travelling to a gov-
ernment hospital to consult a psychiatrist, found it moreaffordable to consult a local private doctor instead. This
local doctor, a cardiologist, had repeated the psychia-
trist’s prescription for alprazolam and olanzapine for the
past two years.
One CBW stated that although the majority of service
users could afford the cost, occasionally the NGO would
need to provide financial assistance. Another explained
that one or two per cent of service users with financial
difficulties decided to revert to using superstitious rem-
edies. In those cases the NGO tried to convince them to
return to the psychiatrist and offered to pay their travel
expenses for the next consultation. In contrast a third
CBW stated that there were many patients who could
not afford the travel expenses, therefore the NGO tried
to provide them with three months of medication, to re-
duce the number of times they were required to attend
the camp. A psychiatrist described two groups of pa-
tients: those who could not afford the cost and those




The World Health Organisation (WHO) regularly pub-
lishes a Model List of Essential Medicines [4]. This is a
list of medications, selected on the basis of disease
prevalence, safety, efficacy and cost-effectiveness, which
satisfy the main healthcare needs of a population. In
addition the WHO advocates the production of local-
ised lists in order to improve supply and increase ra-
tional use.
Bihar produces a customised state level Essential
Drugs List, to be used as a guideline for clinical practise
and an indicator of medication availability at govern-
ment facilities. The list is updated at least every two
years by a core committee of experts and government
officials, using similar criteria to the WHO. The pub-
lished list includes an application form for the inclusion
or deletion of medications. Documents outlining con-
flicts of interest and the specific criteria for medication
selection were unavailable.
The Essential Drugs List, contains separate lists for
PHCs to DHs, and the MCHs. The psychotropic medica-
tions included in the 2013-14, are shown in Table 1. In
comparison to the thirteen psychotropic medications in
the Essential Drugs List, the National List of Essential
Medicines of India 2011 contains fifteen. The medications
included are largely similar, except imipramine, olanza-
pine, lithium carbonate and chlorpromazine hydrochloride
are included in the National List of Essential Medicines
but not Bihar’s Essential Drugs List. In contrast clonaze-
pam and trifluoperazine combined with trihexyphenidyl
are included in Bihar’s Essential Drugs List but not the
National List of Essential Medicines.
Table 1 Psychotropic medications listed in Essential
Drugs List 2013 – 2014 (C-capsule; I-injection; S-syrup;
SS-suspension; T-tablet)
Primary health centres to
district hospitals (out-patients)
Medical College Hospitals
Alprazolam 0.25 mg, 0.5 mg (T) Alprazolam 0.5 mg (T)
Diazepam 5 mg (T) 5 mg/ml (I) Amitriptyline 25 mg (T)
Magnesium sulphate
500 mg/ml (I)
Carbamazepine 100 mg, 200 mg (T)
20 mg/ml (S)
Clonazepam 0.5 mg (T)
Diazepam 2 ml (I) (5 mg/ml)
Fluoxetine 20 mg (C)
Haloperidol 5 mg/ml (I)
Lorazepam 2 mg/ml (I)
Magnesium Sulphate 500 mg/ml (I)
Midazolam 1 mg/ml, 5 ml (I)
Phenobarbitone 20 mg/5 ml (SS)
200 mg/ml (I)
Phenytoin sodium 25 mg/ml (S)
50 mg/ml (I)
Sodium Valproate 200 mg, 500 mg (T)
200 mg/5 ml (S)
Trifluoperazine 5 mg &
Trihexyphenidyl 2 mg (T)
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lection of medications is based on the quantity of medi-
cations distributed during the preceding 3-6 months and
the perception of needs of patients by the consultant
psychiatrists. Psychiatrists involved stated they were not
influenced by pharmaceutical companies and kept in mind
their social responsibility. The following medications were
currently available: olanzapine, risperidone, lithium car-
bonate, sodium valproate, divalproex, clonazepam, fluoxet-
ine, amitryptiline and imipramine. This list contains fewer
medications than Bihar’s Essential Drugs List and more
closely resembles the National List of Essential Medicines
of India due to the inclusion of imipramine, olanzepine,
lithium carbonate and exclusion of trifluoperazine com-
bined with trihexyphenidyl. However, this was an abbrevi-
ated list that was soon to be expanded.
The local NGO, NBJK’s medicine procurement was
also based on the requests of psychiatrists working at
the camps, although it was stipulated that they could
only request molecules rather than brands. The most re-
cent stock list contained 21 medications, which included
all those listed in Bihar’s Essential Drugs List for MCH
out-patients except alprazolam and trifluoperazine com-
bined with trihexyphenidyl.
Procurement
The medication procurement system in Bihar is currently
undergoing change. At present the Bihar State HealthSociety selects and approves manufacturers of medications
on the Essential Drugs List centrally through a tender
process. A ‘cash and carry’ model is then employed at
the district level to purchase medications. An order is
provided biannually by the district-level Civil Surgeon
(PHCs and DH) and the Superintendent of each MCH
directly to suppliers approved by Bihar State Health
Society (Figure 2). The quantity ordered is based on the
previous year’s consumption, disease prevalence, sea-
sonal variation and the expected number of cases for
the next six months. To minimise shortages a buffer
stock of two months is maintained. PHCs and hospitals
are entitled to request medication not included in the
Essential Drugs List, however a tender must then be
floated locally. Budget allocation to each facility is based
on the expected number of patients.
The new system, which is likely to be fully functional
in 2014, aims to also centralise the purchasing and
distribution process in order to minimise delays due to
the need for pharmaceutical manufacturers to receive a
payment from hospitals before supplying medications.
The government has set up the Bihar Medical Services
and Infrastructure Corporation Limited (BMSICL) who
will procure and purchase medications at the state level.
District-level Civil Surgeons and MCH Superintendents
will instead order medications directly from government-
owned BMSICL (Figure 3). It is yet to be decided whether
a small percentage of the system will remain decentralised.
The tender process is the same for both systems. Only
manufacturers of generic medications are invited. There
are two stages to the process; suppliers must satisfy the
technical tender before their financial bid is considered.
The technical tender includes the following criteria: a
minimum market standing of three years, an annual
turnover over Rs 10 crore (approximately US $1.7 mil-
lion), an appropriate manufacturing license, no previous
black-listing. A factory inspection is also conducted in
order to ensure good manufacturing practice. The rate
contract is valid for one year unless specifically ex-
tended and approved suppliers are required to supply
medications within 30 days of receiving an order. In
addition quality is maintained by the requirement for
manufacturers to submit a Test Analysis report and fur-
ther testing of random and suspicious samples. If these
conditions are not met, the government purchases the
medications from the next level bidder, and any additional
cost is recovered from the approved suppliers. Generally a
minimum of 4 to 5 bids are received for each medication
and Indian manufacturers are contracted.
At BIMHAS, the state mental health hospital, the medi-
cines budget and the procurement process are currently
separate to that in government hospitals, although medica-
tions are procured by the standardised process of inviting
tenders. Purchases are then made every 3-6 months.
Figure 2 Procurement model pre-2014 (MCH: medical college hospital).
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cense to purchase wholesale, the NGO, NBJK procure
medications by comparing quotes from three pharmacies
in Jharkhand, where the organisation is based. A stock
list is maintained and purchasing decisions are made
monthly by a core committee based on stock levels.
Distribution
A standard procedure is employed for all government fa-
cilities. At present the distribution channel is privatised.
Medications are transported from the manufacturer to a
distributer within the state and then to a wholesaler.
The medications are distributed to specific facilities from
the wholesaler. Under the new system, the government
have purchased three regional warehouses where medi-
cations will be stored, and are in the process of setting
up a transportation system. A government official ac-
knowledged that flooding caused a challenge to distribu-
tion but generally the government would anticipate the
season and procure additional medications.
Medications for the NGO camps are stored in a locked
office in Bodghaya, and the expiry dates are checked
monthly. They are transported by NBJK staff to each
camp, often by public transport.
Use
All the psychiatrists asked, stated that their prescribing
was based on clinical experience. They believed inde-
pendent guidelines were unnecessary since their training
provided them with sufficient experience. Additionally
they stated that pharmaceutical companies could notFigure 3 Procurement model post-2014 (MCH: medical college hospitinfluence them. Instead they prescribed medications
based on the patient’s financial situation. One explained,
“…if poor patient comes to us, or to my private
chamber, if I write costlier drugs, what will
ultimately happen is the patient will take it for
maximum 1 month, after they will stop taking the
drug.”
Table 2 provides an estimate of consumption quan-
tity for the 2013 tender invitation, based on the previ-
ous two year’s consumption. However, one stakeholder
explained that this data is unreliable:
“Frankly speaking it’s kind of data which some
data entry operator has fed into the computer at
sub-district level and no one knows where the data
has come from. Some of the data would be genuine but it
is showing wide fluctuation in some cases. I mean if I
total the indent for the state, the budgeted figure is 5
times what has been spent last year.”
The Bihar Medical Services and Infrastructure Corpor-
ation Limited are therefore aiming to rectify this by closely
monitoring consumption over time, using a new electronic
system.
Figure 4 shows the consumption trends for different
classes of psychotropic medications over one year in NBJK
camps.
Anticonvulsants are the most commonly prescribed med-
ications followed by antipsychotics and antidepressants. Aal).
Table 2 Estimated annual consumption quantity for the
year 2013-14 (Tablets and capsules unit-10x10; where
different doses of the same drug were provided,
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ate and carbamazepine are the two most frequently pre-
scribed anticonvulsants (Figure 5). This only partially
reflects the government consumption data in which carba-
mazepine consumption appears to greatly exceed the otherFigure 4 Graph showing the number of tablets consumed of differen
August 2013 in NBJK camps.anticonvulsants. In terms of antipsychotics, olanzapine is
the most commonly prescribed at the NBJK camps. The
prescribing of antidepressants appears to be more variable.
Underlying causes of barriers to access and utilisation
A government official believed the lack of availability
of psychotropic medications in PHCs and DHs, and
their limited inclusion in the Essential Drugs List for
these levels, was due to a lack of demand. PHC doctors
confirmed this stating that very few people with mental
illness attended the clinics. However, they explained
that this was due to their lack of facilities and medica-
tion to treat mental illness. One stated,
“…they know there is no facility or doctor in this
hospital or these types of hospitals; they directly go to
Patna or somewhere else.”
This view was reiterated by a stakeholder at Bihar
Medical Services and Infrastructure Corporation
Limited, who stated that consumption figures are
highly dependent on availability. Therefore the cor-
poration expects that once the new procurement sys-
tem is fully functional, and previous problems with
supply are addressed, consumption figures will in-
crease. It is expected that the annual medicines
budget, which in 2013 was roughly 200 crore (ap-
proximately US $33 million), will increase to over
300 crore (approximately US $49 million) due to in-
creased demand.
Within PHCs however, opinion varied about treating
mental illness. One PHC doctor stated that training of
PHC doctors was necessary, whilst another felt thatt classes of psychotropic medication from September 2012 to
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psychiatric doctor. This was supported by a psychiatrist
who stated,
“It (psychotropic medications) should not be freely
available at PHC level. It should be made available
only where a specialist psychiatrist is stationed as part
of the medical team, otherwise it is likely to be
misused.”
In addition, the PHC doctors were unable to name
any psychotropic medications that they would like to be
made available. However they also described the need
for a “social mobiliser” or counsellor, in addition to
medications.
In MCHs, where psychiatrists were present but psy-
chotropic medications were usually unavailable, one
psychiatrist speculated that poor availability may be
due to lack of awareness and sensitivity at the level of
decision makers. However a MCH administrator stated
that they had sufficient funds to purchase the medica-
tions they required, including any essential medica-
tions that the psychiatric department requested. The
administrator and the Head of Department at this
MCH stated that although orders were sent to
suppliers for psychotropic medications, the medica-
tions were often not supplied. This problem was less
common amongst other medications therefore theyFigure 5 Graph showing the average monthly consumption of specif
between September 2012 and August 2013 in NBJK camps.believed it was due to the low volume purchased, both
by the hospital and throughout the state. The low
prices negotiated through the tender process, meant
that supplying psychotropic medications was only
profitable for the pharmaceutical company if large
volumes were purchased.
“There is a vicious circle, two three years back the
State Health Society has approved the rates, and some
of the companies, the rates are so low they are unable
to supply…If I give an order of carbamazepine 10,000
tablets, if it is not in bulk the company will not
supply.”Limitations
This study aimed to analyse the psychotropic medicines
management cycle (selection, procurement, distribu-
tion and use), and identify the access and utilisation
barriers of psychotropic medicines and their underlying
causes. The research was limited by the lack of pharma-
cists willing to participate. As a result it was not pos-
sible to determine their role in the distribution system.
As pharmacists are likely to be a key stakeholder, it is
important that their role is explored further to gain a
more comprehensive understanding of the distribution
system and to identify the source and reliability of con-
sumption data.ic anticonvulsant, antipsychotic and antidepressant medications
Padmanathan et al. International Journal of Mental Health Systems 2014, 8:29 Page 9 of 11
http://www.ijmhs.com/content/8/1/29In addition the effect of the researcher, interpreter and
NGO staff must be considered. For example the presence
of a member of the NGO staff during interviews may have
resulted in response bias. However, confidentiality was
emphasised and efforts were made to ensure service users
in particular did not feel pressurised to respond in a
certain way.
The snowball sampling strategy may have led to sam-
pling bias and limited representativeness, particularly as it
began with the NGO programme manager. This was mini-
mised by ensuring that stakeholders from both the private
and government healthcare sector were also included and
involved in identifying further stakeholders.
Finally the inclusion of only five districts may have
also limited the representativeness of this study. How-
ever as these were central districts in which camps and
BIMHAS were situated, it is likely that the results under-
estimate the significance of barriers such as cost and
distance.
Discussion
Despite these limitations this study raises a number of
points for discussion. Interviews of service users and
CBWs indicate that psychotropic medications are avail-
able in the NGO and private sector. However, cost and
distance are the main barriers to access. The findings
suggest that these barriers could lead to non-adherence
to treatment, and therefore may reduce the effectivenessFigure 6 Cycle of lack of demand by doctors and service users at the
Drugs List).of such treatment. They can also necessitate compromises
in prescribing safety, such as the provision of large quan-
tities of medications to last several months and psychiatric
consultations without the service user being present.
In terms of medicines management, the inclusion of
psychotropic medication in the Essential Drugs List is
promising. However, the lack of availability in MCHs
needs to be explored further. Comparison is required be-
tween the quantity of psychotropic medications ordered
by Heads of Departments and Superintendents and
the quantity supplied. Close monitoring of supply is es-
pecially necessary to investigate the hypothesis that
medications are being ordered but not supplied. If this is
due to the low quantity of medications ordered by each
hospital, the problem may be addressed when Bihar
Medical Services and Infrastructure Corporation Limited
begin purchasing medications in bulk. However, if it is
due to the low volume of medications required by the
state in total, this would add further weight to the scal-
ing up of mental healthcare.
In addition, the reason for the differences between Bihar’s
Essential Drugs List and the medications provided at the
state mental health hospital, BIMHAS needs to be ex-
plored. For example it is unclear why trifluoperazine com-
bined with trihexyphenidyl is one of two anti-psychotics
listed in the Essential Drugs List for MCHs, when con-
sumption appears to be low and it has not been selected
for BIMHAS or the National List of Essential Medicines.primary health centre and district hospital level (EDL: Essential
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appears to be well organised, and the new centralised pro-
curement system has the potential to bring about signifi-
cant improvements. In addition the mandatory testing of
stock is beneficial in ensuring quality is upheld, whilst the
maintenance of a buffer stock and additional procurement
before rainy seasons demonstrates good insight. The dif-
ference between the government and NGO procurement,
storage and distribution processes highlights the effi-
ciency savings and other benefits gained by large-scale
state provision of medications.
The consumption data from NBJK camps provides a
valuable insight into prescribing, since current govern-
ment consumption data is unreliable. It is particularly
interesting that antipsychotics, used for severe mental
disorders, are more commonly prescribed than antide-
pressants which are indicated for common mental
disorders. This may partially reflect the frequent pre-
scription of the antipsychotic, olanzapine for sleeping
difficulties, despite not being an indication for its use in
the National Formulary of India [19]. This irrational use
can lead to harm and therefore would require further in-
vestigation. More importantly it may also suggest that
people with common mental disorders are not accessing
treatment.
Finally, this report highlights the cycle between lack of
demand for treatments for mental illness at the PHC
and district level by doctors and patients, which is the
main barrier to access and use of psychotropic medica-
tions (Figure 6).
Implementation of the revised District Mental Health
Programme has the potential to break this cycle: the
presence of staff trained to treat mental illness using
both pharmacological and psychosocial interventions
will lead to people accessing mental healthcare locally,
which will in turn result in demand for, and supply of,
psychotropic medications. Most importantly this will
address the barriers of availability, cost and distance.
However, for implementation to be a success, resistance
amongst stakeholders to less qualified healthcare staff
being permitted to prescribe must be addressed.
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